Ontario company seeks licence to make generic Johnson and Johnson COVID vaccine for developing countries

  • 📰 nationalpost
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 80%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

A compulsory licence can be granted when a company demonstrates a clear need for generic versions of patented medicine

AdvertisementBiolyse has sought and received a compulsory licence before, for the influenza drug Tamiflu during the H1N1 scare, but the process took seven months and the flu had largely run its course when it received approval. Compulsory licences were also issued to generic drug giant Apotex to send AIDS medications to Rwanda.

“If you can’t use a compulsory licence now, you can’t use Canada’s access to medicines regime now, then what’s the use?” Even with that licence, Johnson and Johnson would not be under any obligation to help Biolyse manufacture the vaccine, it just would have no recourse to stop it under patent law.Article content

 

コメントありがとうございます。コメントは審査後に公開されます。

Who comes first. Canadians or developing countries. This covid19 has taught us one thing here in Canada. We have no Leadership in Ottawa, and JT always goes to China asking for help, instead of doing what GB did.

Developing countries At this point Canada is a Developing country with Trudeau's vaccine failure👎

Better idea: make it for the Canadian market as well.

Cool!

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 10. in JP

日本 最新ニュース, 日本 見出し